サマリー

市場分析と洞察。ナノ構造体医薬品の世界市場
COVID-19のパンデミックにより、ナノ構造体医薬品の世界市場規模は2022年に100万米ドルと推定され、2028年には再調整後の市場規模が100万米ドルになると予測され、検討期間中のCAGRは%となっています。この健康危機による経済的変化を十分に考慮して、リポソームは2021年にナノ構造体医薬品の世界市場の％を占めていましたが、COVID-19後の期間に改訂された％のCAGRで成長し、2028年には100万米ドルになると予測されています。一方、「がん・腫瘍」セグメントは、この予測期間を通じて％のCAGRで変化しています。
中国のナノ構造体医薬品の市場規模は2021年に百万米ドル、米国と欧州のナノ構造体医薬品はそれぞれ百万米ドルと百万米ドルとなっています。米国の割合は2021年には%で、中国とヨーロッパはそれぞれ%と%で、中国の割合は2028年には%に達し、分析期間中のCAGRは%になると予測されています。アジアでは、日本、韓国、東南アジアが注目すべき市場であり、今後6年間のCAGRはそれぞれ％、％、％となっています。ヨーロッパのナノ構造体医薬品市場では、ドイツが2028年までに100万米ドルに達すると予測されており、予測期間中のCAGRは%となっています。
Nanostructured Drugの世界的な主要メーカーには、Merck、Pfizer、Novartis、Abbott、GlaxoSmithKline、Roche、Sanofi、Eli Lilly、Astrazenecaなどがあります。2021年には、世界のトップ5社の売上高シェアは約%となっています。
世界のナノ構造体医薬品のスコープとセグメント
Nanostructured Drug市場は、タイプ別、アプリケーション別に分類されています。世界のNanostructured Drug市場のプレーヤー、ステークホルダー、その他の参加者は、このレポートを強力なリソースとして利用することで、優位に立つことができるでしょう。セグメント分析では、2017年から2028年の期間におけるタイプ別、アプリケーション別の売上高、収益、予測に焦点を当てています。
タイプ別セグメント
リポソーム
ポリマーミセル
固体脂質ナノ粒子
マイクロエマルション、ナノエマルション
ナノサスペンション
用途別セグメント
癌・腫瘍
自己免疫疾患
会社別
メルク
ファイザー
ノバルティス
アボット
GlaxoSmithKline（グラクソ・スミスクライン
ロシュ
サノフィ
イーライリリー
アストラゼネカ
ジョンソン・エンド・ジョンソン
セルジーン
ノババックス
ストライカー
ギリアド・サイエンシズ
OSIファーマシューティカルズ
カドモン・ファーマシューティカルズ
Samyang Biopharm
三菱ウェルファーマ
科研製薬
セレクタ・バイオサイエンシズ
パー・ファーマシューティカル
セルリアンファーマ
ナビデア・バイオファーマシューティカルズ
ラミー
地域別
北アメリカ
U.S.
カナダ
ヨーロッパ
ドイツ
フランス
イギリス
イタリア
ロシア
アジアパシフィック
中国
日本
韓国
インド
オーストラリア
台湾
インドネシア
タイ
マレーシア
フィリピン
ベトナム
ラテンアメリカ
メキシコ
ブラジル
アルゼンチン
中近東・アフリカ
トルコ
サウジアラビア
U.A.E.

ページTOPに戻る

目次

1 Study Coverage
1.1 Nanostructured Drug Product Introduction
1.2 Market by Type
1.2.1 Global Nanostructured Drug Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Liposomes
1.2.3 Polymeric Micelles
1.2.4 Solid lipid Nanoparticles
1.2.5 Microemulsion and Nanoemulsion
1.2.6 Nanosuspension
1.3 Market by Application
1.3.1 Global Nanostructured Drug Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Cancer and Tumors
1.3.3 Autoimmune Disorders
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Nanostructured Drug Sales Estimates and Forecasts 2017-2028
2.2 Global Nanostructured Drug Revenue Estimates and Forecasts 2017-2028
2.3 Global Nanostructured Drug Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Nanostructured Drug Sales by Region
2.4.1 Global Nanostructured Drug Sales by Region (2017-2022)
2.4.2 Global Sales Nanostructured Drug by Region (2023-2028)
2.5 Global Nanostructured Drug Revenue by Region
2.5.1 Global Nanostructured Drug Revenue by Region (2017-2022)
2.5.2 Global Nanostructured Drug Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Nanostructured Drug Sales by Manufacturers
3.1.1 Global Top Nanostructured Drug Manufacturers by Sales (2017-2022)
3.1.2 Global Nanostructured Drug Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Nanostructured Drug in 2021
3.2 Global Nanostructured Drug Revenue by Manufacturers
3.2.1 Global Nanostructured Drug Revenue by Manufacturers (2017-2022)
3.2.2 Global Nanostructured Drug Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Nanostructured Drug Revenue in 2021
3.3 Global Nanostructured Drug Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Nanostructured Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Nanostructured Drug Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Nanostructured Drug Sales by Type
4.1.1 Global Nanostructured Drug Historical Sales by Type (2017-2022)
4.1.2 Global Nanostructured Drug Forecasted Sales by Type (2023-2028)
4.1.3 Global Nanostructured Drug Sales Market Share by Type (2017-2028)
4.2 Global Nanostructured Drug Revenue by Type
4.2.1 Global Nanostructured Drug Historical Revenue by Type (2017-2022)
4.2.2 Global Nanostructured Drug Forecasted Revenue by Type (2023-2028)
4.2.3 Global Nanostructured Drug Revenue Market Share by Type (2017-2028)
4.3 Global Nanostructured Drug Price by Type
4.3.1 Global Nanostructured Drug Price by Type (2017-2022)
4.3.2 Global Nanostructured Drug Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Nanostructured Drug Sales by Application
5.1.1 Global Nanostructured Drug Historical Sales by Application (2017-2022)
5.1.2 Global Nanostructured Drug Forecasted Sales by Application (2023-2028)
5.1.3 Global Nanostructured Drug Sales Market Share by Application (2017-2028)
5.2 Global Nanostructured Drug Revenue by Application
5.2.1 Global Nanostructured Drug Historical Revenue by Application (2017-2022)
5.2.2 Global Nanostructured Drug Forecasted Revenue by Application (2023-2028)
5.2.3 Global Nanostructured Drug Revenue Market Share by Application (2017-2028)
5.3 Global Nanostructured Drug Price by Application
5.3.1 Global Nanostructured Drug Price by Application (2017-2022)
5.3.2 Global Nanostructured Drug Price Forecast by Application (2023-2028)
6 North America
6.1 North America Nanostructured Drug Market Size by Type
6.1.1 North America Nanostructured Drug Sales by Type (2017-2028)
6.1.2 North America Nanostructured Drug Revenue by Type (2017-2028)
6.2 North America Nanostructured Drug Market Size by Application
6.2.1 North America Nanostructured Drug Sales by Application (2017-2028)
6.2.2 North America Nanostructured Drug Revenue by Application (2017-2028)
6.3 North America Nanostructured Drug Market Size by Country
6.3.1 North America Nanostructured Drug Sales by Country (2017-2028)
6.3.2 North America Nanostructured Drug Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Nanostructured Drug Market Size by Type
7.1.1 Europe Nanostructured Drug Sales by Type (2017-2028)
7.1.2 Europe Nanostructured Drug Revenue by Type (2017-2028)
7.2 Europe Nanostructured Drug Market Size by Application
7.2.1 Europe Nanostructured Drug Sales by Application (2017-2028)
7.2.2 Europe Nanostructured Drug Revenue by Application (2017-2028)
7.3 Europe Nanostructured Drug Market Size by Country
7.3.1 Europe Nanostructured Drug Sales by Country (2017-2028)
7.3.2 Europe Nanostructured Drug Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Nanostructured Drug Market Size by Type
8.1.1 Asia Pacific Nanostructured Drug Sales by Type (2017-2028)
8.1.2 Asia Pacific Nanostructured Drug Revenue by Type (2017-2028)
8.2 Asia Pacific Nanostructured Drug Market Size by Application
8.2.1 Asia Pacific Nanostructured Drug Sales by Application (2017-2028)
8.2.2 Asia Pacific Nanostructured Drug Revenue by Application (2017-2028)
8.3 Asia Pacific Nanostructured Drug Market Size by Region
8.3.1 Asia Pacific Nanostructured Drug Sales by Region (2017-2028)
8.3.2 Asia Pacific Nanostructured Drug Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Nanostructured Drug Market Size by Type
9.1.1 Latin America Nanostructured Drug Sales by Type (2017-2028)
9.1.2 Latin America Nanostructured Drug Revenue by Type (2017-2028)
9.2 Latin America Nanostructured Drug Market Size by Application
9.2.1 Latin America Nanostructured Drug Sales by Application (2017-2028)
9.2.2 Latin America Nanostructured Drug Revenue by Application (2017-2028)
9.3 Latin America Nanostructured Drug Market Size by Country
9.3.1 Latin America Nanostructured Drug Sales by Country (2017-2028)
9.3.2 Latin America Nanostructured Drug Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Nanostructured Drug Market Size by Type
10.1.1 Middle East and Africa Nanostructured Drug Sales by Type (2017-2028)
10.1.2 Middle East and Africa Nanostructured Drug Revenue by Type (2017-2028)
10.2 Middle East and Africa Nanostructured Drug Market Size by Application
10.2.1 Middle East and Africa Nanostructured Drug Sales by Application (2017-2028)
10.2.2 Middle East and Africa Nanostructured Drug Revenue by Application (2017-2028)
10.3 Middle East and Africa Nanostructured Drug Market Size by Country
10.3.1 Middle East and Africa Nanostructured Drug Sales by Country (2017-2028)
10.3.2 Middle East and Africa Nanostructured Drug Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Merck
11.1.1 Merck Corporation Information
11.1.2 Merck Overview
11.1.3 Merck Nanostructured Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Merck Nanostructured Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Merck Recent Developments
11.2 Pfizer
11.2.1 Pfizer Corporation Information
11.2.2 Pfizer Overview
11.2.3 Pfizer Nanostructured Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Pfizer Nanostructured Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Pfizer Recent Developments
11.3 Novartis
11.3.1 Novartis Corporation Information
11.3.2 Novartis Overview
11.3.3 Novartis Nanostructured Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Novartis Nanostructured Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Novartis Recent Developments
11.4 Abbott
11.4.1 Abbott Corporation Information
11.4.2 Abbott Overview
11.4.3 Abbott Nanostructured Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Abbott Nanostructured Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Abbott Recent Developments
11.5 GlaxoSmithKline
11.5.1 GlaxoSmithKline Corporation Information
11.5.2 GlaxoSmithKline Overview
11.5.3 GlaxoSmithKline Nanostructured Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 GlaxoSmithKline Nanostructured Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 GlaxoSmithKline Recent Developments
11.6 Roche
11.6.1 Roche Corporation Information
11.6.2 Roche Overview
11.6.3 Roche Nanostructured Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Roche Nanostructured Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Roche Recent Developments
11.7 Sanofi
11.7.1 Sanofi Corporation Information
11.7.2 Sanofi Overview
11.7.3 Sanofi Nanostructured Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Sanofi Nanostructured Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Sanofi Recent Developments
11.8 Eli Lilly
11.8.1 Eli Lilly Corporation Information
11.8.2 Eli Lilly Overview
11.8.3 Eli Lilly Nanostructured Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Eli Lilly Nanostructured Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Eli Lilly Recent Developments
11.9 Astrazeneca
11.9.1 Astrazeneca Corporation Information
11.9.2 Astrazeneca Overview
11.9.3 Astrazeneca Nanostructured Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Astrazeneca Nanostructured Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Astrazeneca Recent Developments
11.10 Johnson & Johnson
11.10.1 Johnson & Johnson Corporation Information
11.10.2 Johnson & Johnson Overview
11.10.3 Johnson & Johnson Nanostructured Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Johnson & Johnson Nanostructured Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Johnson & Johnson Recent Developments
11.11 Celgene
11.11.1 Celgene Corporation Information
11.11.2 Celgene Overview
11.11.3 Celgene Nanostructured Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Celgene Nanostructured Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Celgene Recent Developments
11.12 Novavax
11.12.1 Novavax Corporation Information
11.12.2 Novavax Overview
11.12.3 Novavax Nanostructured Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 Novavax Nanostructured Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Novavax Recent Developments
11.13 Stryker
11.13.1 Stryker Corporation Information
11.13.2 Stryker Overview
11.13.3 Stryker Nanostructured Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 Stryker Nanostructured Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Stryker Recent Developments
11.14 Gilead Sciences
11.14.1 Gilead Sciences Corporation Information
11.14.2 Gilead Sciences Overview
11.14.3 Gilead Sciences Nanostructured Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.14.4 Gilead Sciences Nanostructured Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Gilead Sciences Recent Developments
11.15 OSI Pharmaceuticals
11.15.1 OSI Pharmaceuticals Corporation Information
11.15.2 OSI Pharmaceuticals Overview
11.15.3 OSI Pharmaceuticals Nanostructured Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.15.4 OSI Pharmaceuticals Nanostructured Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 OSI Pharmaceuticals Recent Developments
11.16 Kadmon Pharmaceuticals
11.16.1 Kadmon Pharmaceuticals Corporation Information
11.16.2 Kadmon Pharmaceuticals Overview
11.16.3 Kadmon Pharmaceuticals Nanostructured Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.16.4 Kadmon Pharmaceuticals Nanostructured Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.16.5 Kadmon Pharmaceuticals Recent Developments
11.17 Samyang Biopharm
11.17.1 Samyang Biopharm Corporation Information
11.17.2 Samyang Biopharm Overview
11.17.3 Samyang Biopharm Nanostructured Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.17.4 Samyang Biopharm Nanostructured Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.17.5 Samyang Biopharm Recent Developments
11.18 Mitsubishi Pharma
11.18.1 Mitsubishi Pharma Corporation Information
11.18.2 Mitsubishi Pharma Overview
11.18.3 Mitsubishi Pharma Nanostructured Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.18.4 Mitsubishi Pharma Nanostructured Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.18.5 Mitsubishi Pharma Recent Developments
11.19 Kaken Pharmaceutical
11.19.1 Kaken Pharmaceutical Corporation Information
11.19.2 Kaken Pharmaceutical Overview
11.19.3 Kaken Pharmaceutical Nanostructured Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.19.4 Kaken Pharmaceutical Nanostructured Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.19.5 Kaken Pharmaceutical Recent Developments
11.20 Selecta Biosciences
11.20.1 Selecta Biosciences Corporation Information
11.20.2 Selecta Biosciences Overview
11.20.3 Selecta Biosciences Nanostructured Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.20.4 Selecta Biosciences Nanostructured Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.20.5 Selecta Biosciences Recent Developments
11.21 Par Pharmaceutical
11.21.1 Par Pharmaceutical Corporation Information
11.21.2 Par Pharmaceutical Overview
11.21.3 Par Pharmaceutical Nanostructured Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.21.4 Par Pharmaceutical Nanostructured Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.21.5 Par Pharmaceutical Recent Developments
11.22 Cerulean Pharma
11.22.1 Cerulean Pharma Corporation Information
11.22.2 Cerulean Pharma Overview
11.22.3 Cerulean Pharma Nanostructured Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.22.4 Cerulean Pharma Nanostructured Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.22.5 Cerulean Pharma Recent Developments
11.23 Navidea Biopharmaceuticals
11.23.1 Navidea Biopharmaceuticals Corporation Information
11.23.2 Navidea Biopharmaceuticals Overview
11.23.3 Navidea Biopharmaceuticals Nanostructured Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.23.4 Navidea Biopharmaceuticals Nanostructured Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.23.5 Navidea Biopharmaceuticals Recent Developments
11.24 Lummy
11.24.1 Lummy Corporation Information
11.24.2 Lummy Overview
11.24.3 Lummy Nanostructured Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.24.4 Lummy Nanostructured Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.24.5 Lummy Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Nanostructured Drug Industry Chain Analysis
12.2 Nanostructured Drug Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Nanostructured Drug Production Mode & Process
12.4 Nanostructured Drug Sales and Marketing
12.4.1 Nanostructured Drug Sales Channels
12.4.2 Nanostructured Drug Distributors
12.5 Nanostructured Drug Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Nanostructured Drug Industry Trends
13.2 Nanostructured Drug Market Drivers
13.3 Nanostructured Drug Market Challenges
13.4 Nanostructured Drug Market Restraints
14 Key Findings in The Global Nanostructured Drug Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer